BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Aduro Biotech 

626 Bancroft Way
Suite 3C
Berkeley  California  94710  U.S.A.
Phone: 510-848-4400 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





 Company News
Aduro Biotech Announces Initiation Of Phase 2b ECLIPSE Trial To Evaluate Treatment Of Patients With Pancreatic Cancer With The Company’s Innovative Immunotherapies 2/10/2014 9:50:01 AM    More...
Aduro Biotech Announces Presentations At The Upcoming Aduro Biotech CEO And Investor Conference And Leerink Swann and Company Global Healthcare Conference 1/30/2014 9:29:31 AM    More...
As Big Biotech Talks Cancer Vaccines, Bay Area's Aduro Biotech Nails Mid-Stage Pancreatic Cancer Study 1/15/2014 6:33:46 AM    More...
Aduro Biotech Presents Preclinical Data On Enhanced Anti-Tumor Activity With Small-Molecule Immunotherapy Program 11/14/2013 9:56:58 AM    More...
Aduro Biotech Presents Preclinical Data On Enhanced Anti-Tumor Activity With Small-Molecule Immunotherapy Program 11/14/2013 9:43:23 AM    More...
Aduro Biotech Announces Presentation on Small-Molecule Immunotherapy Program at SITC Conference 11/5/2013 7:13:12 AM    More...
Aduro Biotech Receives Orphan Drug Designation for CRS-207 for Pancreatic Cancer 10/22/2013 10:20:29 AM    More...
Aduro Biotech Announces Poster Presentations of Phase 2 Pancreatic Cancer and Phase 1B Mesothelioma Clinical Trials at American Society of Clinical Oncology 5/20/2013 7:09:17 AM    More...
Aduro Biotech Scientific Advisory Board Member Daniel A. Portnoy Elected to the National Academy of Sciences 5/8/2013 8:01:41 AM    More...
Aduro Biotech Announces Collaboration With Johns Hopkins University to Evaluate Aduro Therapeutic Melanoma Vaccines in Combination With Anti-PD-1 4/22/2013 12:54:39 PM    More...
123

//-->